GFAP in the SCH group was found to be significantly decreased when compared to the Model group (P < 0.05, Figure 4(e)), indicating that the intrathecal injection of ERK1/2 antagonist SCH inhibited the activity of astrocytes in the spinal cord of rats with chronic visceral hypersensitivity. Here, GFAP is linked to spindle cell hemangioma.